“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

If you don't feel hungry as much as you used to, or you are not wanting to eat as much food as you would usually, this could ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

summarize the emergent understanding of molecular subtypes of small cell lung cancer (SCLC ... monitored by serial liquid biopsy-based biomarkers, will be needed to improve the outcomes of ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

Circulating tumor DNA as a prognostic biomarker for long-term survival in de-novo oligometastatic non-small cell lung cancer. The prevalence and outcomes of hypercalcemia in Black American patients ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.